These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8872805)

  • 1. Gender and cardiovascular risk.
    Khaw KT
    J Hum Hypertens; 1996 Jun; 10(6):403-7. PubMed ID: 8872805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sex and gender differences in cardiovascular medicine].
    Akishita M
    Masui; 2009 Jan; 58(1):4-9. PubMed ID: 19175009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project.
    Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
    Prev Med; 2000 Oct; 31(4):335-45. PubMed ID: 11006058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk profiles for cardiovascular events: implications for prevention.
    Kannel WB; Wilson PW
    Adv Intern Med; 1997; 42():39-66. PubMed ID: 9048116
    [No Abstract]   [Full Text] [Related]  

  • 5. Alcohol, cardiovascular diseases and total mortality: the epidemiological evidence.
    Beaglehole R; Jackson R
    N Z Med J; 1991 Jun; 104(914):249-51. PubMed ID: 2057149
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement and cardiovascular risk factors.
    Crook D; Stevenson JC
    N Engl J Med; 1993 Sep; 329(14):1041-2; author reply 1042-3. PubMed ID: 8366909
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular and cellular basis of cardiovascular gender differences.
    Mendelsohn ME; Karas RH
    Science; 2005 Jun; 308(5728):1583-7. PubMed ID: 15947175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?
    Buchanan MR; Brister SJ
    Can J Cardiol; 2001 Nov; 17 Suppl D():7D-13D. PubMed ID: 11726991
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement and cardiovascular risk factors.
    Zumoff B
    N Engl J Med; 1993 Sep; 329(14):1041; author reply 1042-3. PubMed ID: 8366908
    [No Abstract]   [Full Text] [Related]  

  • 11. Gender differences in cardiovascular risk factors.
    Mercuro G; Zoncu S; Dragoni F
    Ital Heart J; 2003 Jun; 4(6):363-6. PubMed ID: 12898798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity and cardiovascular morbidity].
    Berg A; Bönner G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
    [No Abstract]   [Full Text] [Related]  

  • 13. First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study.
    Menotti A; Lanti M; Puddu PE; Mancini M; Zanchetti A; Cirillo M; Vagnarelli OT
    Ital Heart J; 2000 Jun; 1(6):394-9. PubMed ID: 10929739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventive cardiology and cardiac rehabilitation programmes in women.
    Ll Lloyd GW
    Maturitas; 2009 May; 63(1):28-33. PubMed ID: 19321277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein cholesterol and coronary heart disease.
    Young CE; Karas RH; Kuvin JT
    Cardiol Rev; 2004; 12(2):107-19. PubMed ID: 14766026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [When will fibrinogen screening become available?].
    Ernst E
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
    [No Abstract]   [Full Text] [Related]  

  • 18. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus.
    Cockcroft JR; Wilkinson IB; Evans M; McEwan P; Peters JR; Davies S; Scanlon MF; Currie CJ
    Am J Hypertens; 2005 Nov; 18(11):1463-7; discussion 1468-9. PubMed ID: 16280282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.